8-Bromo-5-methyl-[1,2,4]triazolo[1,5-a]pyridine
97%
- Product Code: 150758
CAS:
1172341-29-5
Molecular Weight: | 212.05 g./mol | Molecular Formula: | C₇H₆BrN₃ |
---|---|---|---|
EC Number: | MDL Number: | MFCD12026324 | |
Melting Point: | Boiling Point: | ||
Density: | 1.76±0.1 g/cm3(Predicted) | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its ability to form stable heterocyclic structures that interact with biological targets. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where the bromo group allows for further functionalization via cross-coupling reactions such as Suzuki or Buchwald-Hartwig aminations. Also utilized in research settings for the design of new bioactive molecules with potential anxiolytic, anticonvulsant, or anti-inflammatory properties. Its rigid aromatic framework enhances binding selectivity and metabolic stability in drug candidates.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
0.100 | 10-20 days | ฿12,110.00 |
+
-
|
0.250 | 10-20 days | ฿20,250.00 |
+
-
|
1.000 | 10-20 days | ฿40,500.00 |
+
-
|
8-Bromo-5-methyl-[1,2,4]triazolo[1,5-a]pyridine
Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. It serves as a building block in medicinal chemistry due to its ability to form stable heterocyclic structures that interact with biological targets. Commonly employed in the preparation of active pharmaceutical ingredients (APIs) where the bromo group allows for further functionalization via cross-coupling reactions such as Suzuki or Buchwald-Hartwig aminations. Also utilized in research settings for the design of new bioactive molecules with potential anxiolytic, anticonvulsant, or anti-inflammatory properties. Its rigid aromatic framework enhances binding selectivity and metabolic stability in drug candidates.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :